Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML) - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)

This study has been completed.

Study NCT00079482 Information provided by Cephalon

First Received: March 8, 2004 Last Updated: August 23, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	January 2010
Primary Completion Date:	March 2009 (Final data collection date for primary outcome measure)

No publications provided by Cephalon

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Levis M, Ravandi F, Wang ES, Baer MR, Perl A, Coutre S, Erba H, Stuart RK, Baccarani M, Cripe LD, Tallman MS, Meloni G, Godley LA, Langston AA, Amadori S, Lewis ID, Nagler A, Stone R, Yee K, Advani A, Douer D, Wiktor-Jedrzejczak W, Juliusson G, Litzow MR, Petersdorf S, Sanz M, Kantarjian HM, Sato T, Tremmel L, Bensen-Kennedy DM, Small D, Smith BD. Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. Blood. 2011 Mar 24;117(12):3294-301. Epub 2011 Jan 26.

Back to top of Main Content